* Surgepays Inc SURG.OQ SURG.O is expected to show a
rise in
quarterly revenue when it reports results on March 30.
* The Bartlett Tennessee-based company is expected to
report a
183.3% increase in revenue to $40.1 million from $14.16 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Surgepays Inc is
for a
loss of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Surgepays
Inc is
$12, above its last closing price of $4.30.
This summary was machine generated March 28 at 20:10 GMT. All
figures in US dollars unless otherwise stated